Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert L Atmar

Showing results (141-150 of 261) with videos related to

Pageof 27
Sort By:
Infection Control and Hospital Epidemiology|October 21, 2025
Clinical factors and diagnoses associated with inappropriate urine culture ordering in primary careMarissa Valentine-King, Barbara W Trautner, Michael A Hansen, et al.
Veterinary Immunology and Immunopathology|April 16, 2013
Prenatal passive transfer of maternal immunity in Asian elephants (Elephas maximus)Sally A Nofs, Robert L Atmar, Wendy A Keitel, et al.
The Journal of Infectious Diseases|October 2, 2023
A Bivalent Human Norovirus Vaccine Induces Homotypic and Heterotypic Neutralizing AntibodiesRobert L Atmar, Khalil Ettayebi, Sasirekha Ramani, et al.
Current Opinion in Virology|July 30, 2014
Structural basis of glycan interaction in gastroenteric viral pathogensB V Venkataram Prasad, Sreejesh Shanker, Liya Hu, et al.
Antimicrobial Agents and Chemotherapy|October 3, 2023
Standardization of an antiviral pipeline for human norovirus in human intestinal enteroids demonstrates nitazoxanide has no to weak antiviral activityMiranda A Lewis, Nicolás W Cortés-Penfield, Khalil Ettayebi, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2023
A Standardized Antiviral Pipeline for Human Norovirus in Human Intestinal Enteroids Demonstrates No Antiviral Activity of NitazoxanideMiranda A Lewis, Nicolás W Cortés-Penfield, Khalil Ettayebi, et al.
Clinical and Vaccine Immunology : CVI|November 28, 2014
Mapping broadly reactive norovirus genogroup I and II monoclonal antibodiesSue E Crawford, Nadim Ajami, Tracy Dewese Parker, et al.
Emerging Infectious Diseases|June 22, 2022
Use of Human Intestinal Enteroids to Evaluate Persistence of Infectious Human Norovirus in SeawaterMarion Desdouits, David Polo, Cecile Le Mennec, et al.
Journal of Virology|April 11, 2023
Human Sapovirus Replication in Human Intestinal EnteroidsGabriel Euller-Nicolas, Cécile Le Mennec, Julien Schaeffer, et al.
Journal of Virology|June 17, 2024
Bile acid-sensitive human norovirus strains are susceptible to sphingosine-1-phosphate receptor 2 inhibitionVictoria Tenge, B Vijayalakshmi Ayyar, Khalil Ettayebi, et al.
Pageof 27

Showing results (141-150 of 261) with videos related to

Sort By:
Pageof 27
Infection Control and Hospital Epidemiology|October 21, 2025
Clinical factors and diagnoses associated with inappropriate urine culture ordering in primary careMarissa Valentine-King, Barbara W Trautner, Michael A Hansen, et al.
Veterinary Immunology and Immunopathology|April 16, 2013
Prenatal passive transfer of maternal immunity in Asian elephants (Elephas maximus)Sally A Nofs, Robert L Atmar, Wendy A Keitel, et al.
The Journal of Infectious Diseases|October 2, 2023
A Bivalent Human Norovirus Vaccine Induces Homotypic and Heterotypic Neutralizing AntibodiesRobert L Atmar, Khalil Ettayebi, Sasirekha Ramani, et al.
Current Opinion in Virology|July 30, 2014
Structural basis of glycan interaction in gastroenteric viral pathogensB V Venkataram Prasad, Sreejesh Shanker, Liya Hu, et al.
Antimicrobial Agents and Chemotherapy|October 3, 2023
Standardization of an antiviral pipeline for human norovirus in human intestinal enteroids demonstrates nitazoxanide has no to weak antiviral activityMiranda A Lewis, Nicolás W Cortés-Penfield, Khalil Ettayebi, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2023
A Standardized Antiviral Pipeline for Human Norovirus in Human Intestinal Enteroids Demonstrates No Antiviral Activity of NitazoxanideMiranda A Lewis, Nicolás W Cortés-Penfield, Khalil Ettayebi, et al.
Clinical and Vaccine Immunology : CVI|November 28, 2014
Mapping broadly reactive norovirus genogroup I and II monoclonal antibodiesSue E Crawford, Nadim Ajami, Tracy Dewese Parker, et al.
Emerging Infectious Diseases|June 22, 2022
Use of Human Intestinal Enteroids to Evaluate Persistence of Infectious Human Norovirus in SeawaterMarion Desdouits, David Polo, Cecile Le Mennec, et al.
Journal of Virology|April 11, 2023
Human Sapovirus Replication in Human Intestinal EnteroidsGabriel Euller-Nicolas, Cécile Le Mennec, Julien Schaeffer, et al.
Journal of Virology|June 17, 2024
Bile acid-sensitive human norovirus strains are susceptible to sphingosine-1-phosphate receptor 2 inhibitionVictoria Tenge, B Vijayalakshmi Ayyar, Khalil Ettayebi, et al.
Pageof 27